Australia requires less evidence for premarket application audits
This article was originally published in SRA
Australia’s Therapeutic Goods Administration has reduced the amount of documentary evidence it requires from medical device sponsors applying for premarket application audits in an effort to decrease the existing backlog of applications1. An application audit confirms that a device manufacturer has carried out the conformity assessment procedures appropriate to the class of device.
You may also be interested in...
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.
The UK scheme allows patients with early access to promising new unlicensed medicines when there is a clear unmet medical need.